What is Guillain–Barré?
Guillain Barre Syndrome is an acute inflammatory autoimmune neuritis caused by T cell- mediated cellular immune response directed towards peripheral myelin. The process is often preceded by a viral or bacterial infection, surgery, immunization, lymphoma, or exposure to toxins.
What do patients take to treat Guillain–Barré and its symptoms?
Commonly prescribed and frequently used treatments
| Treatment name | Efficacy | Overall rating of side effects | # of Evaluations |
|---|---|---|---|
| 1 | |||
| 0 |
These charts show data from Guillain–Barré patients' latest treatment evaluations
Who has Guillain–Barré at PatientsLikeMe?
- 35 patients have this condition
- 1 New patient joined this month
- 15 say Guillain–Barré is their primary condition
| <20 | 20-29 | 30-39 | 40-49 | 50-59 | 60-69 | 70+ |
|---|---|---|---|---|---|---|
| Current Age | ||||||
| Gender | |
| 64% | Females |
|---|---|
| 36% | Males |
| Age at first symptom | # of patients | Proportion |
|---|---|---|
| 0-19 yrs | 3 | |
| 20-29 yrs | 2 | |
| 30-39 yrs | 2 | |
| 40-49 yrs | 0 | |
| 50-59 yrs | 5 | |
| 60-69 yrs | 0 | |
| 70+ yrs | 0 |
These charts show data from Guillain–Barré patients who have completed their condition history